Logo image of NAKA

KINDLY MD INC (NAKA) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:NAKA - US49457M1062 - Common Stock

0.4539 USD
+0.01 (+3.16%)
Last: 11/24/2025, 10:52:08 AM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to NAKA. NAKA was compared to 101 industry peers in the Health Care Providers & Services industry. NAKA has a great financial health rating, but its profitability evaluates not so good. NAKA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NAKA had negative earnings in the past year.
NAKA had a negative operating cash flow in the past year.
NAKA Yearly Net Income VS EBIT VS OCF VS FCFNAKA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -1M -2M -3M

1.2 Ratios

NAKA's Return On Assets of -55.28% is on the low side compared to the rest of the industry. NAKA is outperformed by 91.09% of its industry peers.
The Return On Equity of NAKA (-60.97%) is worse than 72.28% of its industry peers.
Industry RankSector Rank
ROA -55.28%
ROE -60.97%
ROIC N/A
ROA(3y)-171.26%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NAKA Yearly ROA, ROE, ROICNAKA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 500 -500 1K

1.3 Margins

NAKA has a better Gross Margin (98.73%) than 100.00% of its industry peers.
In the last couple of years the Gross Margin of NAKA has remained more or less at the same level.
NAKA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 98.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.15%
GM growth 5YN/A
NAKA Yearly Profit, Operating, Gross MarginsNAKA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 50 -50 -100

More info and screens

8

2. Health

2.1 Basic Checks

NAKA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NAKA has more shares outstanding
The debt/assets ratio for NAKA has been reduced compared to a year ago.
NAKA Yearly Shares OutstandingNAKA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M
NAKA Yearly Total Debt VS Total AssetsNAKA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1M 2M 3M

2.2 Solvency

NAKA has an Altman-Z score of 124.15. This indicates that NAKA is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 124.15, NAKA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
NAKA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 124.15
ROIC/WACCN/A
WACC8.85%
NAKA Yearly LT Debt VS Equity VS FCFNAKA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M -2M

2.3 Liquidity

A Current Ratio of 12.99 indicates that NAKA has no problem at all paying its short term obligations.
NAKA has a Current ratio of 12.99. This is amongst the best in the industry. NAKA outperforms 98.02% of its industry peers.
A Quick Ratio of 12.99 indicates that NAKA has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 12.99, NAKA belongs to the best of the industry, outperforming 98.02% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 12.99
Quick Ratio 12.99
NAKA Yearly Current Assets VS Current LiabilitesNAKA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for NAKA have decreased strongly by -85.77% in the last year.
NAKA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -27.67%.
The Revenue has been growing slightly by 2.79% on average over the past years.
EPS 1Y (TTM)-85.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-34.4%
Revenue 1Y (TTM)-27.67%
Revenue growth 3Y2.79%
Revenue growth 5YN/A
Sales Q2Q%-36.08%

3.2 Future

Based on estimates for the next years, NAKA will show a very strong growth in Earnings Per Share. The EPS will grow by 25.35% on average per year.
Based on estimates for the next years, NAKA will show a very strong growth in Revenue. The Revenue will grow by 295.41% on average per year.
EPS Next Y55.16%
EPS Next 2Y41.15%
EPS Next 3Y25.35%
EPS Next 5YN/A
Revenue Next Year-32.72%
Revenue Next 2Y338.3%
Revenue Next 3Y295.41%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NAKA Yearly Revenue VS EstimatesNAKA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
NAKA Yearly EPS VS EstimatesNAKA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.1 -0.2 -0.3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NAKA. In the last year negative earnings were reported.
Also next year NAKA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NAKA Price Earnings VS Forward Price EarningsNAKA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NAKA Per share dataNAKA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

NAKA's earnings are expected to grow with 25.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.15%
EPS Next 3Y25.35%

More info and screens

0

5. Dividend

5.1 Amount

NAKA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KINDLY MD INC

NASDAQ:NAKA (11/24/2025, 10:52:08 AM)

0.4539

+0.01 (+3.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-19 2025-11-19/amc
Earnings (Next)03-26 2026-03-26
Inst Owners0.23%
Inst Owner ChangeN/A
Ins Owners5.05%
Ins Owner Change78.5%
Market Cap199.65M
Revenue(TTM)2.24M
Net Income(TTM)-5.47M
Analysts82.5
Price Target5.1 (1023.6%)
Short Float %5.55%
Short Ratio0.71
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-37.5%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 89.13
P/FCF N/A
P/OCF N/A
P/B 22.26
P/tB 32.75
EV/EBITDA N/A
EPS(TTM)-0.86
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.01
BVpS0.02
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -55.28%
ROE -60.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 98.73%
FCFM N/A
ROA(3y)-171.26%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.15%
GM growth 5YN/A
F-Score4
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2456.96%
Cap/Sales 129.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 12.99
Quick Ratio 12.99
Altman-Z 124.15
F-Score4
WACC8.85%
ROIC/WACCN/A
Cap/Depr(3y)300.3%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.84%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-85.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-34.4%
EPS Next Y55.16%
EPS Next 2Y41.15%
EPS Next 3Y25.35%
EPS Next 5YN/A
Revenue 1Y (TTM)-27.67%
Revenue growth 3Y2.79%
Revenue growth 5YN/A
Sales Q2Q%-36.08%
Revenue Next Year-32.72%
Revenue Next 2Y338.3%
Revenue Next 3Y295.41%
Revenue Next 5YN/A
EBIT growth 1Y-164.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-239.94%
EBIT Next 3Y201.56%
EBIT Next 5YN/A
FCF growth 1Y-649.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-583.85%
OCF growth 3YN/A
OCF growth 5YN/A

KINDLY MD INC / NAKA FAQ

What is the ChartMill fundamental rating of KINDLY MD INC (NAKA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to NAKA.


What is the valuation status of KINDLY MD INC (NAKA) stock?

ChartMill assigns a valuation rating of 1 / 10 to KINDLY MD INC (NAKA). This can be considered as Overvalued.


How profitable is KINDLY MD INC (NAKA) stock?

KINDLY MD INC (NAKA) has a profitability rating of 1 / 10.